Lobak
Lobak Brand names, Lobak Analogs
- Alinam
- Banabil-sintyal
- Banabin
- Banabin-Sintyal
- Banabin-syntyal
- Bisina
- Chlomedinon
- Chlormethazanone
- Chlormethazone
- Chlormezanon
- Chlormezanone [BAN:INN:JAN]
- Chlormezanonum [INN-Latin]
- Clorilax
- Clormetazanone
- Clormetazon
- Clormezanona [INN-Spanish]
- Clormezanone [DCIT]
- Dichloromethazanone
- Dichloromezanone
- Fenarol
- Lobak
- Mio-Sed
- Miorilax
- Muskel
- Muskel-Trancopal
- Myolespen
- Phenarol
- Rexan
- Rilansyl
- Rilaquil
- Rilasol
- Rilassol
- Rilax
- Rillasol
- Supotran
- Suprotan
- Tanafol
- Trancopal
- Trancote
- Tranrilax
- Transanate
- dl-Chlormezanone
Lobak Brand Names Mixture
- No information avaliable
Lobak Chemical_Formula
C11H12ClNO3S
Lobak RX_link
No information avaliable
Lobak fda sheet
Lobak msds (material safety sheet)
Lobak Synthesis Reference
No information avaliable
Lobak Molecular Weight
273.737 g/mol
Lobak Melting Point
116.2 oC
Lobak H2O Solubility
2500 mg/L (hardly soluble)
Lobak State
Solid
Lobak LogP
1.208
Lobak Dosage Forms
No information avaliable
Lobak Indication
Used in the management of anxiety and in the treatment of muscle spasm.
Lobak Pharmacology
Chlormezanone is a non-benzodiazepine muscle relaxant. It was discontinued worldwide in 1996 by its manufacturer due to confirmed serious and rare cutaneous reactions (toxic epidermal necrolysis).
Lobak Absorption
No information avaliable
Lobak side effects and Toxicity
Symptoms of overdose include drowsiness, weakness, nausea, dizziness, abdominal pain, cerebral oedema and renal tubular necrosis, hyperglycaemia and hypoglycaemia, liver damage, encephalopathy, coma and death.
Lobak Patient Information
No information avaliable
Lobak Organisms Affected
Humans and other mammals
